“…The b 3 class of the integrin family, a IIb b 3 (GPIIb/IIIa or fibrinogen receptor) and a V b 3 (vitronectin receptor), has received special attention in recent drug research. [4,5] a IIb b 3 is prevalent on platelets and plays a role in thromboembolic disorders, [5] while a V b 3 is the dominant receptor for mediating the attachment of osteoclasts to bone during bone resorption [6,7] and has been implicated in tumor progression, angiogenesis, [5,8,9] and restenosis. [10] Many integrins, including a IIb b 3 and a V b 3 , interact with a common Arg-Gly-Asp (RGD) binding motif in their target proteins.…”